Yes, which probably makes me less biased. I'm very qualified to understand the medicine. There's a reason Gavin Shepherd is backing this. They definitely have blockbuster potential and a wide range of applications in oncology. My concern is that from a purely financial point of view they look tenuous without an injection of capital or a capital raise. If they were financially more secure I'd join the party with no hesitation.
PTX Price at posting:
4.2¢ Sentiment: Hold Disclosure: Not Held
